Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment

BJU International

Volumn 108, Issue 2, 2011, Pages 248-251

  Watanabe, Toyohiko ^a   Inoue, Miayabi ^a   Sasaki, Katsumi ^a   Araki, Motoo ^a   Uehara, Shinya ^a   Monden, Koichi ^a   Saika, Takashi ^a   Nasu, Yasutomo ^a   Kumon, Hiromi ^a   Chancellor, Michael B ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b BEAUMONT HOSPITAL   (United States)

Author keywords

chronic pelvic pain syndrome; chronic prostatitis; nerve growth factor; prostate

Indexed keywords

CERNITIN; NAFTOPIDIL; NERVE GROWTH FACTOR; QUINOLONE;

ADULT; AGED; ARTICLE; CHRONIC PROSTATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAGNETOTHERAPY; MALE; NATIONAL INSTITUTES OF HEALTH CHRONIC PROSTATITIS SYMPTOMS INDEX; PAIN ASSESSMENT; PELVIS PAIN SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE FLUID; PROSTATE SECRETION; PROTEIN EXPRESSION; SCORING SYSTEM; TREATMENT RESPONSE;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; BIOLOGICAL MARKERS; BODILY SECRETIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGIC METHODS; HUMANS; MAGNETIC FIELD THERAPY; MALE; MIDDLE AGED; NAPHTHALENES; NERVE GROWTH FACTOR; PAIN MEASUREMENT; PIPERAZINES; PROSTATE; PROSTATITIS; QUINOLONES; TREATMENT OUTCOME;

EID: 79959952666     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09716.x     Document Type: Article

References (18)

1. Krieger JN, Nyberg L Jr, Nickel JC,. NIH consensus definition and classification of prostatitis. JAMA 1999; 282: 236-7 (Pubitemid 29343164)
2. Nickel JC, Downey J, Hunter D, Clark J,. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol 2001; 165: 842-5 (Pubitemid 32156292)
3. McNaughton Collins M, Pontari MA, O'Leary MP, et al,. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med 2001; 16: 656-62 (Pubitemid 32964845)
4. Pontari MA, Ruggieri MR,. Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol 2004; 172: 839-45 (Pubitemid 39096404)
5. Pezet S, McMahon SB,. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 2006; 29: 507-38 (Pubitemid 44476854)
6. Miller LJ, Fischer KA, Goralnick SJ, et al,. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002; 59: 603-8 (Pubitemid 34249905)
7. Propert KJ, Alexander RB, Nickel JC, et al,. Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology 2002; 59: 870-6 (Pubitemid 34522179)
8. Okragly AJ, Haak-Frendscho M,. An acid-treatment method for the enhanced detection of GDNF in biological samples. Exp Neurol 1997; 145: 592-6 (Pubitemid 27314811)
9. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al,. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999; 162: 369-75 (Pubitemid 29434343)
10. Monden K, Tsugawa M, Ninomiya Y, Ando E, Kumon H,. [A Japanese version of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI, Okayama version) and the clinical evaluation of cernitin pollen extract for chronic non-bacterial prostatitis]. Nippon Hinyokika Gakkai Zasshi 2002; 93: 539-47 (Pubitemid 34601362)
11. Dellabella M, Milanese G, Sigala S, et al,. The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome. Inflamm Res 2009; 58: 829-36
12. Nickel JC, Alexander RB, Schaeffer AJ, et al,. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 2003; 170: 818-22 (Pubitemid 36999565)
13. Schaeffer AJ, Knauss JS, Landis JR, et al,. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002; 168: 1048-53
14. Hochreiter WW, Nadler RB, Koch AE, et al,. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology 2000; 56: 1025-9
15. Alexander RB, Ponniah S, Hasday J, Hebel JR,. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology 1998; 52: 744-9 (Pubitemid 28489692)
16. Yokoyama T, Kumon H, Nagai A,. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder. Neurourol Urodyn 2008; 27: 417-20 (Pubitemid 351991207)
17. Steers WD, Tuttle JB,. Mechanisms of Disease: the role of nerve growth factor in the pathophysiology of bladder disorders. Nat Clin Pract Urol 2006; 3: 101-10 (Pubitemid 43239267)
18. Kim JC, Kim DB, Seo SI, Park YH, Hwang TK,. Nerve growth factor and vanilloid receptor expression, and detrusor instability, after relieving bladder outlet obstruction in rats. BJU Int 2004; 94: 915-8 (Pubitemid 39472496)